Copyright Reports & Markets. All rights reserved.

Global and United States Medical Hemostatic Agents Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Medical Hemostatic Agents Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Medical Hemostatic Agents Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Medical Hemostatic Agents Market Size Growth Rate by Type
    • 1.4.2 Gelation Sponge
    • 1.4.3 Oxidized Regenerated Cellulose Based Hemostats
    • 1.4.4 Others
  • 1.5 Market by Application
    • 1.5.1 Global Medical Hemostatic Agents Market Size Growth Rate by Application
    • 1.5.2 Hospitals
    • 1.5.3 Surgical Centers
    • 1.5.4 Clnics
    • 1.5.5 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Medical Hemostatic Agents Market Size, Estimates and Forecasts
    • 2.1.1 Global Medical Hemostatic Agents Revenue 2015-2026
    • 2.1.2 Global Medical Hemostatic Agents Sales 2015-2026
  • 2.2 Global Medical Hemostatic Agents, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Medical Hemostatic Agents Historical Market Size by Region (2015-2020)
    • 2.3.1 Global Medical Hemostatic Agents Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global Medical Hemostatic Agents Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 Medical Hemostatic Agents Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Medical Hemostatic Agents Sales Forecast by Region (2021-2026)
    • 2.4.2 Global Medical Hemostatic Agents Revenue Forecast by Region (2021-2026)

3 Global Medical Hemostatic Agents Competitor Landscape by Players

  • 3.1 Global Top Medical Hemostatic Agents Sales by Manufacturers
    • 3.1.1 Global Medical Hemostatic Agents Sales by Manufacturers (2015-2020)
    • 3.1.2 Global Medical Hemostatic Agents Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global Medical Hemostatic Agents Manufacturers by Revenue
    • 3.2.1 Global Medical Hemostatic Agents Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global Medical Hemostatic Agents Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Medical Hemostatic Agents Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Medical Hemostatic Agents Revenue in 2019
    • 3.2.5 Global Medical Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global Medical Hemostatic Agents Price by Manufacturers
  • 3.4 Global Medical Hemostatic Agents Manufacturing Base Distribution, Product Types
    • 3.4.1 Medical Hemostatic Agents Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Medical Hemostatic Agents Product Type
    • 3.4.3 Date of International Manufacturers Enter into Medical Hemostatic Agents Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Medical Hemostatic Agents Market Size by Type (2015-2020)
    • 4.1.1 Global Medical Hemostatic Agents Sales by Type (2015-2020)
    • 4.1.2 Global Medical Hemostatic Agents Revenue by Type (2015-2020)
    • 4.1.3 Medical Hemostatic Agents Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Medical Hemostatic Agents Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Medical Hemostatic Agents Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Medical Hemostatic Agents Revenue Forecast by Type (2021-2026)
    • 4.2.3 Medical Hemostatic Agents Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Medical Hemostatic Agents Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Medical Hemostatic Agents Market Size by Application (2015-2020)
    • 5.1.1 Global Medical Hemostatic Agents Sales by Application (2015-2020)
    • 5.1.2 Global Medical Hemostatic Agents Revenue by Application (2015-2020)
    • 5.1.3 Medical Hemostatic Agents Price by Application (2015-2020)
  • 5.2 Medical Hemostatic Agents Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Medical Hemostatic Agents Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Medical Hemostatic Agents Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Medical Hemostatic Agents Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application

  • 6.1 United States Medical Hemostatic Agents Market Size YoY Growth 2015-2026
    • 6.1.1 United States Medical Hemostatic Agents Sales YoY Growth 2015-2026
    • 6.1.2 United States Medical Hemostatic Agents Revenue YoY Growth 2015-2026
    • 6.1.3 United States Medical Hemostatic Agents Market Share in Global Market 2015-2026
  • 6.2 United States Medical Hemostatic Agents Market Size by Players (International and Local Players)
    • 6.2.1 United States Top Medical Hemostatic Agents Players by Sales (2015-2020)
    • 6.2.2 United States Top Medical Hemostatic Agents Players by Revenue (2015-2020)
  • 6.3 United States Medical Hemostatic Agents Historic Market Review by Type (2015-2020)
    • 6.3.1 United States Medical Hemostatic Agents Sales Market Share by Type (2015-2020)
    • 6.3.2 United States Medical Hemostatic Agents Revenue Market Share by Type (2015-2020)
    • 6.3.3 United States Medical Hemostatic Agents Price by Type (2015-2020)
  • 6.4 United States Medical Hemostatic Agents Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 United States Medical Hemostatic Agents Sales Forecast by Type (2021-2026)
    • 6.4.2 United States Medical Hemostatic Agents Revenue Forecast by Type (2021-2026)
    • 6.4.3 United States Medical Hemostatic Agents Price Forecast by Type (2021-2026)
  • 6.5 United States Medical Hemostatic Agents Historic Market Review by Application (2015-2020)
    • 6.5.1 United States Medical Hemostatic Agents Sales Market Share by Application (2015-2020)
    • 6.5.2 United States Medical Hemostatic Agents Revenue Market Share by Application (2015-2020)
    • 6.5.3 United States Medical Hemostatic Agents Price by Application (2015-2020)
  • 6.6 United States Medical Hemostatic Agents Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 United States Medical Hemostatic Agents Sales Forecast by Application (2021-2026)
    • 6.6.2 United States Medical Hemostatic Agents Revenue Forecast by Application (2021-2026)
    • 6.6.3 United States Medical Hemostatic Agents Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America Medical Hemostatic Agents Market Size YoY Growth 2015-2026
  • 7.2 North America Medical Hemostatic Agents Market Facts & Figures by Country
    • 7.2.1 North America Medical Hemostatic Agents Sales by Country (2015-2020)
    • 7.2.2 North America Medical Hemostatic Agents Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe Medical Hemostatic Agents Market Size YoY Growth 2015-2026
  • 8.2 Europe Medical Hemostatic Agents Market Facts & Figures by Country
    • 8.2.1 Europe Medical Hemostatic Agents Sales by Country
    • 8.2.2 Europe Medical Hemostatic Agents Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Medical Hemostatic Agents Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific Medical Hemostatic Agents Market Facts & Figures by Country
    • 9.2.1 Asia Pacific Medical Hemostatic Agents Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific Medical Hemostatic Agents Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America Medical Hemostatic Agents Market Size YoY Growth 2015-2026
  • 10.2 Latin America Medical Hemostatic Agents Market Facts & Figures by Country
    • 10.2.1 Latin America Medical Hemostatic Agents Sales by Country
    • 10.2.2 Latin America Medical Hemostatic Agents Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Medical Hemostatic Agents Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Medical Hemostatic Agents Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Medical Hemostatic Agents Sales by Country
    • 11.2.2 Middle East and Africa Medical Hemostatic Agents Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 U.A.E

12 Company Profiles

  • 12.1 Ethicon
    • 12.1.1 Ethicon Corporation Information
    • 12.1.2 Ethicon Description and Business Overview
    • 12.1.3 Ethicon Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 Ethicon Medical Hemostatic Agents Products Offered
    • 12.1.5 Ethicon Recent Development
  • 12.2 Pfizer
    • 12.2.1 Pfizer Corporation Information
    • 12.2.2 Pfizer Description and Business Overview
    • 12.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 Pfizer Medical Hemostatic Agents Products Offered
    • 12.2.5 Pfizer Recent Development
  • 12.3 Baxter International
    • 12.3.1 Baxter International Corporation Information
    • 12.3.2 Baxter International Description and Business Overview
    • 12.3.3 Baxter International Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 Baxter International Medical Hemostatic Agents Products Offered
    • 12.3.5 Baxter International Recent Development
  • 12.4 C. R. Bard
    • 12.4.1 C. R. Bard Corporation Information
    • 12.4.2 C. R. Bard Description and Business Overview
    • 12.4.3 C. R. Bard Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 C. R. Bard Medical Hemostatic Agents Products Offered
    • 12.4.5 C. R. Bard Recent Development
  • 12.5 The Medicines Company
    • 12.5.1 The Medicines Company Corporation Information
    • 12.5.2 The Medicines Company Description and Business Overview
    • 12.5.3 The Medicines Company Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 The Medicines Company Medical Hemostatic Agents Products Offered
    • 12.5.5 The Medicines Company Recent Development
  • 12.6 Anika Therapeutics
    • 12.6.1 Anika Therapeutics Corporation Information
    • 12.6.2 Anika Therapeutics Description and Business Overview
    • 12.6.3 Anika Therapeutics Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 Anika Therapeutics Medical Hemostatic Agents Products Offered
    • 12.6.5 Anika Therapeutics Recent Development
  • 12.7 Advanced Medical Solutions
    • 12.7.1 Advanced Medical Solutions Corporation Information
    • 12.7.2 Advanced Medical Solutions Description and Business Overview
    • 12.7.3 Advanced Medical Solutions Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 Advanced Medical Solutions Medical Hemostatic Agents Products Offered
    • 12.7.5 Advanced Medical Solutions Recent Development
  • 12.8 Integra LifeSciences
    • 12.8.1 Integra LifeSciences Corporation Information
    • 12.8.2 Integra LifeSciences Description and Business Overview
    • 12.8.3 Integra LifeSciences Sales, Revenue and Gross Margin (2015-2020)
    • 12.8.4 Integra LifeSciences Medical Hemostatic Agents Products Offered
    • 12.8.5 Integra LifeSciences Recent Development
  • 12.9 B Braun Melsungen
    • 12.9.1 B Braun Melsungen Corporation Information
    • 12.9.2 B Braun Melsungen Description and Business Overview
    • 12.9.3 B Braun Melsungen Sales, Revenue and Gross Margin (2015-2020)
    • 12.9.4 B Braun Melsungen Medical Hemostatic Agents Products Offered
    • 12.9.5 B Braun Melsungen Recent Development
  • 12.10 Gelita Medical
    • 12.10.1 Gelita Medical Corporation Information
    • 12.10.2 Gelita Medical Description and Business Overview
    • 12.10.3 Gelita Medical Sales, Revenue and Gross Margin (2015-2020)
    • 12.10.4 Gelita Medical Medical Hemostatic Agents Products Offered
    • 12.10.5 Gelita Medical Recent Development
  • 12.11 Ethicon
    • 12.11.1 Ethicon Corporation Information
    • 12.11.2 Ethicon Description and Business Overview
    • 12.11.3 Ethicon Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 Ethicon Medical Hemostatic Agents Products Offered
    • 12.11.5 Ethicon Recent Development
  • 12.12 Vascular Solutions
    • 12.12.1 Vascular Solutions Corporation Information
    • 12.12.2 Vascular Solutions Description and Business Overview
    • 12.12.3 Vascular Solutions Sales, Revenue and Gross Margin (2015-2020)
    • 12.12.4 Vascular Solutions Products Offered
    • 12.12.5 Vascular Solutions Recent Development
  • 12.13 Marine Polymer Technologies
    • 12.13.1 Marine Polymer Technologies Corporation Information
    • 12.13.2 Marine Polymer Technologies Description and Business Overview
    • 12.13.3 Marine Polymer Technologies Sales, Revenue and Gross Margin (2015-2020)
    • 12.13.4 Marine Polymer Technologies Products Offered
    • 12.13.5 Marine Polymer Technologies Recent Development
  • 12.14 Z-Medica
    • 12.14.1 Z-Medica Corporation Information
    • 12.14.2 Z-Medica Description and Business Overview
    • 12.14.3 Z-Medica Sales, Revenue and Gross Margin (2015-2020)
    • 12.14.4 Z-Medica Products Offered
    • 12.14.5 Z-Medica Recent Development
  • 12.15 CryoLife
    • 12.15.1 CryoLife Corporation Information
    • 12.15.2 CryoLife Description and Business Overview
    • 12.15.3 CryoLife Sales, Revenue and Gross Margin (2015-2020)
    • 12.15.4 CryoLife Products Offered
    • 12.15.5 CryoLife Recent Development
  • 12.16 BioCer Entwicklungs
    • 12.16.1 BioCer Entwicklungs Corporation Information
    • 12.16.2 BioCer Entwicklungs Description and Business Overview
    • 12.16.3 BioCer Entwicklungs Sales, Revenue and Gross Margin (2015-2020)
    • 12.16.4 BioCer Entwicklungs Products Offered
    • 12.16.5 BioCer Entwicklungs Recent Development
  • 12.17 Biom’Up SAS
    • 12.17.1 Biom’Up SAS Corporation Information
    • 12.17.2 Biom’Up SAS Description and Business Overview
    • 12.17.3 Biom’Up SAS Sales, Revenue and Gross Margin (2015-2020)
    • 12.17.4 Biom’Up SAS Products Offered
    • 12.17.5 Biom’Up SAS Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Medical Hemostatic Agents Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Medical Hemostatic Agents Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Medical Hemostatic Agents market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Medical Hemostatic Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Segment by Type, the Medical Hemostatic Agents market is segmented into
    Gelation Sponge
    Oxidized Regenerated Cellulose Based Hemostats
    Others

    Segment by Application, the Medical Hemostatic Agents market is segmented into
    Hospitals
    Surgical Centers
    Clnics
    Others

    Regional and Country-level Analysis
    The Medical Hemostatic Agents market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Medical Hemostatic Agents market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

    Competitive Landscape and Medical Hemostatic Agents Market Share Analysis
    Medical Hemostatic Agents market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Medical Hemostatic Agents business, the date to enter into the Medical Hemostatic Agents market, Medical Hemostatic Agents product introduction, recent developments, etc.
    The major vendors covered:
    Ethicon
    Pfizer
    Baxter International
    C. R. Bard
    The Medicines Company
    Anika Therapeutics
    Advanced Medical Solutions
    Integra LifeSciences
    B Braun Melsungen
    Gelita Medical
    Equimedical
    Vascular Solutions
    Marine Polymer Technologies
    Z-Medica
    CryoLife
    BioCer Entwicklungs
    Biom’Up SAS

    Buy now